1[8]Musgrave DS, Bosch P, Ghivizzani S, et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone, 1999, 24 (6): 541-547
2[9]Okubo Y, Bessho K, Fujimura K, et al. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun, 2000, 267 (1): 382-387
3[10]Baltzer AW, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther, 2000,7(9):734-739
4[1]Scaduto AA, Lieberman JR. Gene therapy for osteoinduction. Orthop Clin North Am,1999, 30 (4): 625-633
5[2]Franceschi RT, Wang D, Krebsbach PH, et al. Gene therapy for bone formation: In vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem, 2000, 78 (3): 476-486
6[4]Gonda K, Nakaoka T, Yoshimura K, et al. Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene. J Bone Miner Res, 2000, 15 (6):1056-1065
7[5]Krebsbach PH, Gu K, Franceschi RT, et al. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther, 2000, 11 (8):1201-1210
8[6]Gazit D, Turgeman G, Kelley P, et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J Gene Med, 1999,1(2):121-133
9Bhatia A, Prakash S. Topical phenytoin for wound healing[J]. Dermatol Online J, 2004, 10(1):5.
10Vijayasingham SM, Dykes PJ, Marks R Phenytoin has little effect on in vitro models of wound healing[J]. Br J Dermatol, 1991, 125(2) : 136-139.
